Advanced search
Publication Cover
International Journal of Women's Health Volume 13, 2021 - Issue
Submit an article Journal homepage
161
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Effect of Low-Dose Aspirin in Preventing Early-Onset Preeclampsia in the Taiwanese Population—A Retrospective Cohort Study

Kim-Seng Law1 Department of Obstetrics and Gynecology, Tung’s Taichung Metro Harbor Hospital, Taichung, Taiwan;2 Department of Nursing, Jenteh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan;3 Department of Life Science, National Chung Hsing University, Taichung, TaiwanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2484-3761
ORCID Icon &
Tien-Yung Wei1 Department of Obstetrics and Gynecology, Tung’s Taichung Metro Harbor Hospital, Taichung, Taiwan
Pages 1095-1101 | Published online: 12 Nov 2021

References

  • Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33:130–137. doi:10.1053/j.semperi.2009.02.010
  • Chaiworapongsa T, Chaemsaithonh P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10:466–480. doi:10.1038/nrneph.2014.102
  • Roberts JM, Taylor RN, Musci TJ, et al. Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200–1204. doi:10.1016/0002-9378(89)90665-0
  • Redman CW, Sacks GP, Sargent IL. Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. AM J Obstet Gynecol. 1999;180:499–506. doi:10.1016/S0002-9378(99)70239-5
  • Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet. 2005;365:785–799. doi:10.1016/S0140-6736(05)17987-2
  • Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for preeclampsia by maternal characteristics and maternal history. Am J Obstet Gynecol. 2015;213:62.e1–e10. doi:10.1016/j.ajog.2015.02.018
  • Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstet Gynecol Int. 2014;2014:29739. doi:10.1155/2014/297397
  • Akolekar R, Syngelaki A, Poon L, et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33:8–15. doi:10.1159/000341264
  • Poon LC, Akolekar R, Beta J, et al. Hypertensive disorder in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks. Ultrasound Obstet Gynecol. 2010;35:662–670.
  • Tan MY, Syngelaki A, Poon LC, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound Obstet Gynecol. 2018;52:186–195. doi:10.1002/uog.19112
  • Roberge S, Nocolaides KH, Demers S, et al. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2013;41:491–499. doi:10.1002/uog.12421
  • O’Gorman N, Wright D, Rolnik DL, et al. Study protocol for the randomized controlled trial: combined multiple markers screening and randomized patient treatment with aspirin for evidence-based PREeclampsia prevention (ASPRE). BMJ Open. 2016;6:e011801. doi:10.1136/bmjopen-2016-011801
  • Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613–622. doi:10.1056/NEJMoa1704559
  • ACOG Committee Opinion. No 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132:e44–e52. doi:10.1097/AOG.0000000000002708
  • Seidler AL, Askie L, Ray JG. Optimal aspirin dosing for preeclampsia prevention. Am J Obstet Gynecol. 2018;219:117–118. doi:10.1016/j.ajog.2018.03.018
  • Li YY, Gu QR, Chen GR, et al. Preventing preterm preeclampsia. Am J Obstet Gynecol. 2018;219:633–634. doi:10.1016/j.ajog.2018.08.027
  • Zeisler H, Llurb E, Chantraine F, et al. Predictive value of the sFLt-1: PlGFratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13–22. doi:10.1056/NEJMoa1414838
  • Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2020;S0002-9378(20)30741-9. doi:10.1016/j.ajog.2020.07.020
  • Lin L, Huai J, Li B, et al. A randomized controlled trial of low-dose aspirin for the prevention of pre-eclampsia in women at high-risk in China (the APPEC study). Am J Obstet Gynecol. 2021. doi:10.1016/j.ajog.2021.08.004
  • Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy. A meta-analysis. Obstet Gynecol. 2010;116(2):402–414. doi:10.1097/AOG.0b013e3181e9322a
  • Watanabe N, Fujiwara T, Suzuki T, et al. Is in vitro fertilization associated with preeclampsia? A propensity score matched study. BMC Pregnancy Childbirth. 2014;14:69. doi:10.1186/1471-2393-14-69

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.